Understanding What Class of Drug Is Blonanserin?
•
4 min read
First approved in Japan in 2008 for the treatment of schizophrenia, blonanserin is categorized as an atypical, or second-generation, antipsychotic. It is distinguished by its potent antagonism of both dopamine D2 and serotonin 5-HT2A receptors, a dual mechanism that defines its therapeutic effects.
